Skip to main content
SpringerLink
Log in

The genetics of Behçet’s disease in a Chinese population

  • Review
  • Published:
Frontiers of Medicine Aims and scope Submit manuscript

Abstract

Behçet’s disease is defined as a multisystemic inflammatory disease. Although the precise pathogenesis and etiology is still a mystery, accumulating evidence shows that genetic variants of immune-related genes have a profound influence on the development of Behçet’s disease. To explore the genetic factors for Behçet’s disease, our group investigated the association of Behçet’s disease with multiple immune response genes and has identified multiple Behçet’s disease-related immunoregulatory pathways in the Chinese Han population. A large number of gene polymorphisms were studied including STAT4, IL23R, CD40, CCR1/CCR3, STAT3, OPN, IL17, JAK2, MCP-1, CTLA4, PD-1, PD-L1, PD-L2, TGRBR3, CCR6, PTPN22, FCRL3, IRF5, SUMO4 and UBAC2. Significant associations were found between Behçet’s disease and STAT4, IL23R, CD40, CCR1/CCR3, STAT3, MCP-1, TGFBR3, FCRL3, SUMO4, UBAC2. These genetic predisposition studies support an important role for both lymphocyte differentiation as well as ubiquitination pathways. These findings are helpful in elucidating the pathogenesis of Behçet’s disease and hopefully will allow the development of novel treatment regimes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, Howson JM, Stevens H, McManus R, Wijmenga C, Heap GA, Dubois PC, Clayton DG, Hunt KA, van Heel DA, Todd JA. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008; 359(26): 2767–2777

    Article  PubMed  CAS  Google Scholar 

  2. Evereklioglu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol 2005; 50(4): 297–350

    Article  PubMed  Google Scholar 

  3. James DG. Silk Route disease. Postgrad Med J 1986; 62(725): 151–153

    Article  PubMed  CAS  Google Scholar 

  4. Yoshida A, Kawashima H, Motoyama Y, Shibui H, Kaburaki T, Shimizu K, Ando K, Hijikata K, Izawa Y, Hayashi K, Numaga J, Fujino Y, Masuda K, Araie M. Comparison of patients with Behçet’s disease in the 1980s and 1990s. Ophthalmology 2004; 111(4): 810–815

    Article  PubMed  Google Scholar 

  5. Yang P, Zhang Z, Zhou H, Li B, Huang X, Gao Y, Zhu L, Ren Y, Klooster J, Kijlstra A. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 2005; 30(11): 943–948

    Article  PubMed  Google Scholar 

  6. Escudier M, Bagan J, Scully C. Number VII Behçet’s disease (Adamantiades syndrome). Oral Dis 2006; 12(2): 78–84

    Article  PubMed  CAS  Google Scholar 

  7. Azizlerli G, Köse AA, Sarica R, Gül A, Tutkun IT, Kulaç M, Tunç R, Urgancioğlu M, Dişçi R. Prevalence of Behçet’s disease in Istanbul, Turkey. Int J Dermatol 2003; 42(10): 803–806

    Article  PubMed  Google Scholar 

  8. Gül A. Behçet’s disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 2005; 4(1): 81–83

    Article  PubMed  Google Scholar 

  9. Hou S, Yang P, Du L, Zhou H, Lin X, Liu X, Kijlstra A. SUMO4 gene polymorphisms in Chinese Han patients with Behçet’s disease. Clin Immunol 2008; 129(1):170–175

    Article  PubMed  CAS  Google Scholar 

  10. de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A. HLA-B51/B5 and the risk of Behçet’s disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 2009; 61(10): 1287–1296

    Article  PubMed  Google Scholar 

  11. Krause L, Köhler AK, Altenburg A, Papoutsis N, Zouboulis CC, Pleyer U, Stroux A, Foerster MH. Ocular involvement is associated with HLA-B51 in Adamantiades-Behçet’s disease. Eye (Lond) 2009; 23(5): 1182–1186

    Article  CAS  Google Scholar 

  12. Gül A, Hajeer AH, Worthington J, Barrett JH, Ollier WE, Silman AJ. Evidence for linkage of the HLA-B locus in Behçet’s disease, obtained using the transmission disequilibrium test. Arthritis Rheum 2001; 44(1): 239–240

    Article  PubMed  Google Scholar 

  13. Mizuki N, Ota M, Katsuyama Y, Yabuki K, Ando H, Shiina T, Nomura E, Onari K, Ohno S, Inoko H. HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Behçet’s disease. Tissue Antigens 2001; 58(3): 181–184

    Article  PubMed  CAS  Google Scholar 

  14. Li H, Yang P, Jiang Z, Hou S, Xie L. Lack of association of two polymorphisms of IRF5 with Behçet’s disease. Mol Vis 2009; 15: 2018–2021

    PubMed  CAS  Google Scholar 

  15. Kelly JA, Kelley JM, Kaufman KM, Kilpatrick J, Bruner GR, Merrill JT, James JA, Frank SG, Reams E, Brown EE, Gibson AW, Marion MC, Langefeld CD, Li QZ, Karp DR, Wakeland EK, Petri M, Ramsey-Goldman R, Reveille JD, Vilá LM, Alarcón GS, Kimberly RP, Harley JB, Edberg JC. Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun 2008; 9(3): 187–194

    Article  PubMed  CAS  Google Scholar 

  16. Dideberg V, Kristjansdottir G, Milani L, Libioulle C, Sigurdsson S, Louis E, Wiman AC, Vermeire S, Rutgeerts P, Belaiche J, Franchimont D, Van Gossum A, Bours V, Syvänen AC. An insertion-deletion polymorphism in the interferon regulatory factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum Mol Genet 2007; 16(24): 3008–3016

    Article  PubMed  CAS  Google Scholar 

  17. Rueda B, Reddy MV, González-Gay MA, Balsa A, Pascual-Salcedo D, Petersson IF, Eimon A, Paira S, Scherbarth HR, Pons-Estel BA, González-Escribano MF, Alarcón-Riquelme ME, Martín J. Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis. Arthritis Rheum 2006; 54(12): 3815–3819

    Article  PubMed  CAS  Google Scholar 

  18. Kristjansdottir G, Sandling JK, Bonetti A, Roos IM, Milani L, Wang C, Gustafsdottir SM, Sigurdsson S, Lundmark A, Tienari PJ, Koivisto K, Elovaara I, Pirttilä T, Reunanen M, Peltonen L, Saarela J, Hillert J, Olsson T, Landegren U, Alcina A, Fernández O, Leyva L, Guerrero M, Lucas M, Izquierdo G, Matesanz F, Syvänen AC. Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet 2008; 45(6): 362–369

    Article  PubMed  CAS  Google Scholar 

  19. Zhang Q, Hou S, Jiang Z, Du L, Li F, Xiao X, Kijlstra A, Yang P. No association of PTPN22 polymorphisms with susceptibility to ocular Behçet’s disease in two Chinese Han populations. PLoS ONE 2012; 7(3): e31230

    Article  PubMed  CAS  Google Scholar 

  20. Baranathan V, Stanford MR, Vaughan RW, Kondeatis E, Graham E, Fortune F, Madanat W, Kanawati C, Ghabra M, Murray PI, Wallace GR. The association of the PTPN22 620W polymorphism with Behçet’s disease. Ann Rheum Dis 2007; 66(11): 1531–1533

    Article  PubMed  Google Scholar 

  21. Du L, Yang P, Hou S, Zhou H, Kijlstra A. No association of CTLA-4 polymorphisms with susceptibility to Behçet disease. Br J Ophthalmol 2009; 93(10): 1378–1381

    Article  PubMed  CAS  Google Scholar 

  22. Zhang YJ, Xu WD, Duan ZH, Liu SS, Pan HF, Ye DQ. Lack of association between CTLA-4 + 49A/G and - 318C/T polymorphisms and Behçet’s disease risk: a meta-analysis. Clin Exp Rheumatol 2012 Sep 25. [Epub ahead of print]

  23. Bye L, Modi N, Stanford MR, Kondeatis E, Vaughan R, Fortune F, Kanawati C, Ben-Chetrit E, Ghabra M, Murray PI, Wallace GR. CTLA-4 polymorphisms are not associated with ocular inflammatory disease. Tissue Antigens 2008; 72(1): 49–53

    Article  PubMed  CAS  Google Scholar 

  24. Ben Dhifallah I, Chelbi H, Braham A, Hamzaoui K, Houman MH. CTLA-4 + 49A/G polymorphism is associated with Behçet’s disease in a Tunisian population. Tissue Antigens 2009; 73(3): 213–217

    Article  PubMed  CAS  Google Scholar 

  25. Xu Y, Song G. The role of CD40-CD154 interaction in cell immunoregulation. J Biomed Sci 2004; 11(4): 426–438

    Article  PubMed  CAS  Google Scholar 

  26. Chen F, Hou S, Jiang Z, Chen Y, Kijlstra A, Rosenbaum JT, Yang P. CD40 gene polymorphisms confer risk of Behçet’s disease but not of Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Rheumatology (Oxford) 2012; 51(1): 47–51

    Article  CAS  Google Scholar 

  27. Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, Burtt NP, Gianniny L, Korman BD, Padyukov L, Kurreeman FA, Chang M, Catanese JJ, Ding B, Wong S, van der Helm-van Mil AH, Neale BM, Coblyn J, Cui J, Tak PP, Wolbink GJ, Crusius JB, van der Horst-Bruinsma IE, Criswell LA, Amos CI, Seldin MF, Kastner DL, Ardlie KG, Alfredsson L, Costenbader KH, Altshuler D, Huizinga TW, Shadick NA, Weinblatt ME, de Vries N, Worthington J, Seielstad M, Toes RE, Karlson EW, Begovich AB, Klareskog L, Gregersen PK, Daly MJ, Plenge RM. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008; 40(10): 1216–1223

    Article  PubMed  CAS  Google Scholar 

  28. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008; 26(1): 677–704

    Article  PubMed  CAS  Google Scholar 

  29. Meng Q, Guo H, Hou S, Jiang Z, Kijlstra A, Yang P. Lack of an association of PD-1 and its ligand genes with Behçet’s disease in a Chinese Han population. PLoS ONE 2011; 6(10): e25345

    Article  PubMed  CAS  Google Scholar 

  30. Kong EK, Prokunina-Olsson L, Wong WH, Lau CS, Chan TM, Alarcón-Riquelme M, Lau YL. A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum 2005; 52(4): 1058–1062

    Article  PubMed  CAS  Google Scholar 

  31. Kroner A, Mehling M, Hemmer B, Rieckmann P, Toyka KV, Mäurer M, Wiendl H. A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol 2005; 58(1): 50–57

    Article  PubMed  CAS  Google Scholar 

  32. Prokunina L, Castillejo-López C, Oberg F, Gunnarsson I, Berg L, Magnusson V, Brookes AJ, Tentler D, Kristjansdóttir H, Gröndal G, Bolstad AI, Svenungsson E, Lundberg I, Sturfelt G, Jönssen A, Truedsson L, Lima G, Alcocer-Varela J, Jonsson R, Gyllensten UB, Harley JB, Alarcón-Segovia D, Steinsson K, Alarcón-Riquelme ME. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002; 32(4): 666–669

    Article  PubMed  CAS  Google Scholar 

  33. Di Marzio P, Dai WW, Franchin G, Chan A Y, Symons M, Sherry B. Role of Rho family GTPases in CCR1- and CCR5-induced actin reorganization in macrophages. Biochem Biophys Res Commun 2005; 331(4): 909–916

    Article  PubMed  Google Scholar 

  34. Saeki T, Naya A. CCR1 chemokine receptor antagonist. Curr Pharm Des 2003; 9(15): 1201–1208

    Article  PubMed  CAS  Google Scholar 

  35. Penido C, Castro-Faria-Neto HC, Vieira-de-Abreu A, Figueiredo RT, Pelled A, Martins MA, Jose PJ, Williams TJ, Bozza PT. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin. Am J Respir Cell Mol Biol 2001; 25(6): 707–716

    PubMed  CAS  Google Scholar 

  36. Hou S, Xiao X, Li F, Jiang Z, Kijlstra A, Yang P. Two-stage association study in Chinese Han identifies two independent associations in CCR1/CCR3 locus as candidate for Behçet’s disease susceptibility. Hum Genet 2012 Jul 25. [Epub ahead of print]

  37. Kirino Y, Bertsias G, Ombrello MJ, Ustek D, Satorius C, Le J, Mizuki N, Ishigatsubo Y, Seyahi E, Sacli FS, Gul A, Kastner DL, Remmers E. Genome-Wide Analysis of Imputed Genotypes Identifies Chemokine Receptor-1 CCR1) As a Novel Candidate Risk Locus in Behçet’s Disease. Arthritis Rheum 2011; 63(10): S946

    Google Scholar 

  38. Hu K, Yang P, Jiang Z, Hou S, Du L, Li F. STAT4 polymorphism in a Chinese Han population with Vogt-Koyanagi-Harada syndrome and Behçet’s disease. Hum Immunol 2010; 71(7): 723–726

    Article  PubMed  CAS  Google Scholar 

  39. Hou S, Yang Z, Du L, Jiang Z, Shu Q, Chen Y, Li F, Zhou Q, Ohno S, Chen R, Kijlstra A, Rosenbaum JT, Yang P. Genome-wide association study identifies susceptible locus in STAT4 for Behçet’s disease in Han Chinese. Arthritis Rheum 2012 Sep 22. [Epub ahead of print].

  40. Chu M, Yang P, Hou S, Li F, Chen Y, Kijlstra A. Behçet’s disease exhibits an increased osteopontin serum level in active stage but no association with osteopontin and its receptor gene polymorphisms. Hum Immunol 2011; 72(6): 525–529

    Article  PubMed  CAS  Google Scholar 

  41. Jiang Z, Yang P, Hou S, Du L, Xie L, Zhou H, Kijlstra A. IL-23R gene confers susceptibility to Behçet’s disease in a Chinese Han population. Ann Rheum Dis 2010; 69(7): 1325–1328

    Article  PubMed  CAS  Google Scholar 

  42. Hu K, Hou S, Jiang Z, Kijlstra A, Yang P. JAK2 and STAT3 polymorphisms in a Han Chinese population with Behçet’s disease. Invest Ophthalmol Vis Sci 2012; 53(1): 538–541

    Article  PubMed  CAS  Google Scholar 

  43. Shu Q, Yang P, Hou S, Li F, Chen Y, Du L, Jiang Z. Interleukin-17 gene polymorphism is associated with Vogt-Koyanagi-Harada syndrome but not with Behçet’s disease in a Chinese Han population. Hum Immunol 2010; 71(10): 988–991

    Article  PubMed  CAS  Google Scholar 

  44. Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, Ito N, Kera J, Okada E, Yatsu K, Song YW, Lee EB, Kitaichi N, Namba K, Horie Y, Takeno M, Sugita S, Mochizuki M, Bahram S, Ishigatsubo Y, Inoko H. Genome-wide association studies identify IL23RIL12RB2 and IL10 as Behçet’s disease susceptibility loci. Nat Genet 2010; 42(8): 703–706

    Article  PubMed  CAS  Google Scholar 

  45. Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, Le JM, Yang B, Korman BD, Cakiris A, Aglar O, Emrence Z, Azakli H, Ustek D, Tugal-Tutkun I, Akman-Demir G, Chen W, Amos CI, Dizon MB, Kose AA, Azizlerli G, Erer B, Brand OJ, Kaklamani VG, Kaklamanis P, Ben-Chetrit E, Stanford M, Fortune F, Ghabra M, Ollier WE, Cho YH, Bang D, O’shea J, Wallace GR, Gadina M, Kastner DL, Gül A. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet’s disease. Nat Genet 2010; 42(8): 698–702

    Article  PubMed  CAS  Google Scholar 

  46. Hou S, Yang P, Du L, Jiang Z, Mao L, Shu Q, Zhou H, Kijlstra A. Monocyte chemoattractant protein-1 -2518 A/G single nucleotide polymorphism in Chinese Han patients with ocular Behçet’s disease. Hum Immunol 2010; 71(1): 79–82

    Article  PubMed  CAS  Google Scholar 

  47. Yi X, Yang P, Du L, Jiang Z, Li F. There is no association of CCR6 polymorphisms with susceptibility to Behçet’s disease in two Chinese Han populations. Br J Ophthalmol 2011; 95(11): 1603–1606

    Article  PubMed  Google Scholar 

  48. Chen Y, Yang P, Li F, Hou S, Jiang Z, Shu Q, Kijlstra A. Association analysis of TGFBR3 gene with Vogt-Koyanagi-Harada disease and Behçet’s disease in the Chinese Han population. Curr Eye Res 2012; 37(4): 312–317

    Article  PubMed  CAS  Google Scholar 

  49. Fei Y, Webb R, Cobb BL, Direskeneli H, Saruhan-Direskeneli G, Sawalha AH. Identification of novel genetic susceptibility loci for Behçet’s disease using a genome-wide association study. Arthritis Res Ther 2009; 11(3): R66

    Article  PubMed  Google Scholar 

  50. Hou S, Shu Q, Jiang Z, Chen Y, Li F, Chen F, Kijlstra A, Yang P. Replication study confirms the association between UBAC2 and Behçet’s disease in two independent Chinese sets of patients and controls. Arthritis Res Ther 2012; 14(2): R70

    Article  PubMed  CAS  Google Scholar 

  51. Sawalha AH, Hughes T, Nadig A, Yılmaz V, Aksu K, Keser G, Cefle A, Yazıcı A, Ergen A, Alarcón-Riquelme ME, Salvarani C, Casali B, Direskeneli H, Saruhan-Direskeneli G. A putative functional variant within the UBAC2 gene is associated with increased risk of Behçet’s disease. Arthritis Rheum 2011; 63(11): 3607–3612

    Article  PubMed  CAS  Google Scholar 

  52. Fakhfakh Karray E, Bendhifallah I, Zakraoui L, Hamzaoui K. Association of small ubiquitin-like modifier 4 gene polymorphisms with rheumatoid arthritis in a Tunisian population. Clin Exp Rheumatol 2011; 29(4): 751

    PubMed  CAS  Google Scholar 

  53. Park G, Kim HS, Choe JY, Kim SK. SUMO4 C438T polymorphism is associated with papulopustular skin lesion in Korean patients with Behçet’s disease. Rheumatol Int 2012;32(10):3031–3037

    Article  PubMed  CAS  Google Scholar 

  54. Li K, Zhao M, Hou S, Du L, Kijlstra A, Yang P. Association between polymorphisms of FCRL3, a non-HLA gene, and Behçet’s disease in a Chinese population with ophthalmic manifestations. Mol Vis 2008; 14: 2136–2142

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China

    Shengping Hou & Peizeng Yang

  2. Chongqing Eye Institute and Chongqing Key Laboratory of Ophthalmology, Chongqing, 400016, China

    Shengping Hou & Peizeng Yang

  3. University Eye Clinic Maastricht, Maastricht, Limburg, the Netherlands

    Aize Kijlstra

Authors
  1. Shengping Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aize Kijlstra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peizeng Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peizeng Yang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hou, S., Kijlstra, A. & Yang, P. The genetics of Behçet’s disease in a Chinese population. Front. Med. 6, 354–359 (2012). https://doi.org/10.1007/s11684-012-0234-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-012-0234-2

Keywords

Search

Navigation